Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats

Molecular Brain Research

Volumn 50, Issue 1-2, 1997, Pages 205-212

  Stahel, Philip F ^a   Kossmann, Thomas ^b   Morganti Kossmann, Maria C ^b   Hans, Volkmar H J ^b   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chemotactic receptor; Complement; Neuron; Traumatic brain injury

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; MESSENGER RNA; RECEPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELL INFILTRATION; CEREBELLUM; COMPLEMENT SYSTEM; CONTROLLED STUDY; IN SITU HYBRIDIZATION; LATERAL BRAIN VENTRICLE; LEUKOCYTE; LEUKOCYTE MIGRATION; MALE; MENINX; NERVE FIBER; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; ANTIGENS, CD; AXONS; BRAIN INJURIES; CEREBRAL VENTRICLES; COMPLEMENT C5A; IN SITU HYBRIDIZATION; LEUKOCYTES; MALE; MENINGES; RATS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER;

ANIMALIA;

EID: 0030664870     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00189-7     Document Type: Article

References (62)

1. J.H. Adams, D. Doyle, I. Ford, T.A. Gennarelli, D.I. Graham, D.R. McLellan, Diffuse axonal injury in head injury: definition, diagnosis and grading, Histopathology 15 (1989) 49-59.
2. P. Becker, S. Zeigler, U. Rother, H. Lutz, H. Osswald, Complement activation following severe head injury, Anaesthesist 36 (1987) 301-306.
3. B.-M. Bellander, H. von Holst, P. Fredman, M. Svensson, Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat, J. Neurosurg. 85 (1996) 468-475.
4. R. Bullock, Y. Kuroda, G.M. Teasdale, J. McCulloch, Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties, Acta Neurochir. 55 (Suppl.) (1992) 49-55.
5. P.H. Chan, J.W. Schmidley, R.A. Fishman, S.M. Longar, Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 34 (1984) 315-320.
6. R.S.B. Clark, P.M. Kochanek, M.A. Schwarz, J.K. Schiding, D.S. Turner, M. Chen, T.M. Carlos, S.C. Watkins, Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats, Pediatr. Res. 39 (1996) 784-790.
7. R.S.B. Clark, P.M. Kochanek, W.D. Obrist, H.R. Wong, T.R. Billiar, S.R. Wisniewski, D.W. Marion, Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans, Crit. Care Med. 24 (1996) 1243-1251.
8. R.S.B. Clark, T.M. Carlos, J.K. Schiding, M. Bree, L.A. Fireman, S.T. DeKosky, P.M. Kochanek, Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats, J. Neurotrauma 13 (1996) 333-341.
9. W.D. Davis, R.L. Brey, Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin. Exp. Rheumatol. 10 (1992) 455-460.
10. I. Dusart, C. Sotelo, Lack of Purkinje cell loss in adult rat cerebellum following protracted axotomy: degenerative changes and regenerative attempts of the severed axons, J. Comp. Neurol. 347 (1994) 211-232.
11. J.D. Ernst, K.T. Hartiala, I.M. Goldsien, A.M. Sande, Complement (CS)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis, Infect. Immun. 46 (1984) 81-86.
12. A.I. Faden, P. Demediuk, S.S. Panter, R. Vink, The role of excitatory amino acids and NMDA receptors in traumatic brain injury, Science 244 (1989) 798-800.
13. I. Farkas, L. Baranyi, N. Okada, Z. Liposits, H. Okada, A complement C5a fragment peptide causes apoptosis in TGW neuroblastoma cells, Neurobiol. Aging 17 (Suppl. 4) (1996) S183, (Abstract).
14. P.M. Faustmann, D. Krause, R. Dux, R. Dermietzel, Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes, Acta Neuropathol. 89 (1995) 239-247.
15. M.A. Foda, A. Marmarou, A new model of diffuse brain injury in rats Part II: morphological characterisation. J. Neurosurg. 80 (1994) 301-313.
16. K. Fukuda, N. Aihara, S.M. Sagar, F.R. Sharp, L.H. Pitts, J. Honkaniemi, L.J. Noble, Purkinjc cell vulnerability to mild traumatic brain injury, J. Neurotrauma 13 (1996) 255-266.
17. P. Gasque, P. Chan, M. Fontaine, A Ischenko, M. Lamacz, O. Götze, B.P. Morgan, Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes, J. Immunol. 155 (1995) 4882-4889.
18. P. Gasque, S.K. Singhrao, J.W. Neal, O. Götze, B.P. Morgan, Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia. and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1997) 31-41.
19. S.M. Gentleman, G.W. Roberts, T.A. Gennarelli, W.L. Maxwell, J.H. Adams, S. Kerr, D.I. Graham. Axonal injury: a universal consequence of fatal closed head injury'?, Acta Neuropathol. 89 (1995) 537-543.
20. C. Gerard, L. Bao, O. Orozco, M. Pearson, D. Kunz, N.P. Gerard, Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor, J. Immunol. 149 (1992) 2600-2606.
21. C. Gerard, N.P. Gerard, C5a anaphylatoxin and its seven transmembrane-segment receptor, Annu. Rev. Immunol. 12 (1994) 775-808.
22. D. Giulian, K. Vaca, M. Corpuz, Brain glia release factors with opposing actions upon neuronal survival, J. Neurosci. 13 (1993) 29-37.
23. C. Harrison-Felix, C.N. Newton, K.M. Hall, J.S. Kreutzer. Descriptive findings from the traumatic brain injury model systems national data base, J. Head Trauma Rehabil. 11 (1996) 1-14.
24. S. Hill, E. Barbarese, T.K. Mclntosh, Regional heterogeneity in the response of astrocytes following traumatic brain injury in the adult rat, J. Neuropathol. Exp. Neurol. 55 (1996) 1221-1229.
25. R. Horuk, A.W. Martin, Z. Wang, L. Schweitzer, A. Gerassimides, H. Guo, Z. Lu, J. Hesselgesser, H.D. Perez, J. Kim, J. Parker, T.J. Hadley, S.C. Peiper, Expression of chemokine receptors by subsets of neurons in the central nervous system, J. Immunol. 158 (1997) 2882-2890.
26. B. Jennett, Epidemiology of head injury, J. Neurol. Neurosurg. Psychiatry 60 (1996) 362-369.
27. S.A. Johnson, M. Lampert-Etchells, G.M. Pasinetti, I. Rozovsky. C.E. Finch, Complement mRNA in the mammalian brain: response to Alzheimer's disease and experimental brain lesioning, Neurobiol. Aging 13 (1992) 641-648.
28. S.L. Kaczorowski, J.K. Schiding, C.A. Toth, P.M. Kochanek, Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats, J. Cereb. Blood Flow Metab. 15 (1995) 860-864.
29. J.L. Kadurugamuwa, B. Hengstler, M.A. Bray, O. Zak, Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis, J. Infect. Dis. 160 (1989) 715-719.
30. H. Kasuya, T. Shimizu, Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage, J. Neurosurg. 71 (1989) 741-746.
31. K.S. Kim, C.A. Wass, A.S. Cross, S.M. Opal, Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat, Lymphokine Cytokine Res. 11 (1992) 293-298.
32. P.M. Kochanek, Ischemic and traumatic brain injury: pathobiology and cellular mechanisms, Crit. Care Med. 21 (1993) S333-S335.
33. T. Kossmann, V. Hans, H.-G. Imhof, O. Trentz, M.C. Morganti-Kossmann, Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes, Brain Res. 713 (1996) 143-152.
34. T. Kossmann, V.H.J. Hans, P.M. Lenzlinger, E. Csuka, P.F. Stahel, O. Trentz, M.C. Morganti-Kossmann, Analysis of immune mediator production following traumatic brain injury, in: G. Schlag, H. Redl, D. Traber (Eds.), Shock, Sepsis and Organ Failure - Brain Damage Secondary to Hemorrhagic-Traumatic Shock. Sepsis and Traumatic Brain Injury, Springer. Berlin, 1997, pp. 263-304.
35. T. Kossmann, P.F. Stahel, M.C. Morganti-Kossmann, J.L. Jones, S.R. Barnum, Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury, J. Neuroimmunol. 73 (1997) 63-69.
36. T. Kossmann, P.P. Stahel, P.M. Lenzlinger, H. Redl. R.W. Dubs, O. Trentz, G. Schlag, M.C. Morganti-Kossmann, Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production, J. Cereb. Blood Flow Metab. 17 (1997) 280-289.
37. M. Lacy, J. Jones, S.R. Whittemore, D.L. Haviland, R.A. Wetsel, S.R. Barnum, Expression of the peceptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia, J. Neuroimmunol. 61 (1995) 71-78.
38. P.J. Lindsberg, J. Ohman, T. Lehto, M.-L. Karjalainen-Lindsberg, A. Paetau, T. Wuorimaa, O. Carpén, M. Kaste, S Meri, Complement activation in the central nervous system following blood-brain barrier damage in man, Ann. Neurol. 40 (1996) 587-596.
39. M.S. Luer, D.H. Rhoney, M. Hughes, J. Hatton, New pharmacologic strategies for acute neuronal injury, Pharmacotherapy 16 (1996) 830-848.
40. A. Marmarou, M.A. Foda, W. van den Brink, J. Campbell, H. Kita, K. Demetriadou, A new model of diffuse brain injury in rats Part I: pathophysiology and biomechanics, J. Neurosurg. 80 (1994) 291-300.
41. L.F. Marshall, T. Gautille, M.R. Klauber, H.M. Eisenberg, J.A. Jane, T.G. Luerssen, A. Marmarou, M.A. Foulkes, The outcome of severe closed head injury, J. Neurosurg. 75 (1991 ) S28-S36.
42. L.F. Marshall, S. Bowers Marshall, M.R. Klauber, M. van Berkum Clark, H.M. Eisenberg, J.A. Jane, T.G. Luerssen, A. Marmarou, M.A. Foulkes, A new classification of head injury based on computerized tomography, J. Neurosurg. 75 (1991) S14-S20.
43. M.C. Morganti-Kossmann, T. Kossmann, The immunology of brain injury, in: N.J. Rothwell (Ed.), Immune Responses of the Nervous System, Bios. Sci. Publ., Oxford, 1995. pp. 158-187.
44. U. Müller-Ladner, J.L. Jones, R.A. Wetsel, S. Gay, C. Raine, S.R. Barnum, Enhanced expression of chemotactic receptors in multiple sclerosis lesions, J. Neurol. Sci. 144 (1996) 135-141.
45. P.M. Murphy, The molecular biology of leukocyte chemoattructant receptors, Annu. Rev. Immunol. 12 (1994) 593-633.
46. M. Oppermann. O. Götze, Plasma clearance of the human C5a anaphylatoxin by binding to leukocyte C5a receptors, Immunology 82 (1994) 516-521.
47. G.M. Pasinetti, S.A. Johnson, I. Rozovsky, M. Lampert-Etchells, D.G. Morgan, M.N. Gordon, T.E. Morgan, D. Willoughby, C.E. Finch, Complement ClqB und C4 mRNAs responses to lesioning in rat brain, Exp. Neurol. 118 (1992) 117-125.
48. V.J. Quagliarello, B. Wispeley, W.J. Long Jr., W.M. Scheid. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat, J. Clin. Invest. 87 (1991) 1360-1366.
49. O. Ramilo, X. Saez-Llorens, J. Mertsola, H. Jafari, K.D. Olsen, E.J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, G.H. McCracken Jr., Tumor necrosis factor α / cachectin and inlerleukin l β initiate meningeal inflammation, J. Exp. Med. 172 (1990) 497-507.
50. A. Rink, K.M. Fung, J.Q. Trojanowski, V.M.Y. Lee, E. Neugebauer, T.K. Mclntosh, Evidence for apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147 (1995) 1575-1583.
51. H.L. Rosomoff, P.M. Kochanek, R. Clark, S.T. DeKosky, U. Ebmeyer, A.N.A. Grenvik, D.W. Marion, W. Obrist, A.M. Palmer, P. Safar, R.J. White, Resuscitation from severe brain trauma. Crit. Care Med. 24 (Suppl.) (1996) S48-S56.
52. J. Roth, P. Saremaslani, M.J Warhol, P.U. Heitz, Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridisation using a gold-labeled horseradish peroxidase antibody and silver imensitication. Lab. Invest. 67 (1992) 263-269.
53. K. Saukkonen, S. Sande, C Cioffe, S. Wolpe, B. Sherry, A. Cerami, E. Tuomanen, The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis, J. Exp. Med. 171 (1990) 439-448.
54. K. Spiegel, M. Emmerling, S.R. Barnum, Acute phase proteins: strategies for inhibition ol complement activation in the treatment of neurodegenerative diseases, in: P. Woods (Ed.), Inflammatory Mechanisms and Management of Neurodegeneralion, Humana Press, Totowa, NJ, in press.
55. P.E. Stahel, K. Frei, H.-P. Eugster, A. Fontana, K.M. Hummel, R.A. Wetsel, R.S. Ames, S.R. Barnum, TNF-α-mediated expression of the receptor for anaphylaloxin C5a on neurons in experimental Listeria meningoencephalitis, J. Immunol. 159 (1997) 861-869.
56. E. Törnqvist, L. Liu, H. Aldskogius, H. von Holst, M. Svensson, Complement and clusterin in the injured nervous system. Neurobiol. Aging 17 (1996) 695-705.
57. E. Tuomanen, B. Hengstler, O. Zak, A. Tomasz, The role of complement in inflammation during experimental pneumococcal meningitis, Microb. Pathogen 1 (1986) 15-32.
58. S.J. Weiss, Tissue destruction by neutrophils, N. Engl. J. Med. 320 (1989) 365-376
59. R.A. Wetsel. Structure, function and cellular expression of complement anaphylatoxin receptors, Curr. Opin. Immunol. 7 (1995) 48-53.
60. M. Xia, S. Qin, M. McNamara, B.T. Hyman, Type B IL-8 receptor (IL-8RB) in neuritic plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 619, (Abstract).
61. A. Yaghmai, J. Povlishock, Traumatically induced reactive change as visualized through the use of monoclonal antibodies targeted to neurofilament subunits, J. Neuropathol. Exp. Neurol. 51 (1992) 158-176.
62. A. Zwahlen, U.E. Nydegger, P. Vaudaux, P.-H. Lambert, F.A. Waldvogel, Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis, J. Infect. Dis. 145 (1982) 635-646.